June 5, 2018 / 4:12 AM / 20 days ago

BUZZ-India's Biocon hits record high after FDA approves partner's drug

** Shares of Biocon Ltd rise as much as 6.4 pct to record high of 696.60 rupees

** Co’s partner Mylan NV said on Monday U.S. FDA approved its biosimilar to Amgen Inc’s Neulasta

** Mylan and Biocon said they expect to launch the infection-fighting drug, Fulphila, in the coming weeks

** More than 2.3 mln shares of Biocon change hands as of 0400 GMT, compared with 30-day moving avg of 2 mln

** As of Monday’s close, Biocon stock had nearly doubled in value in the past 12 months

** Mylan shares rose 5.2 pct to $40.50 after market on Monday

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below